With its FDA approval, JenaValve intends to commence launch activity for the Trilogy System immediately with participating ...

JenaValve's Trilogy System, FDA-approved for severe AR, offers secure anchoring without calcium. It is a breakthrough for high-risk U.S. patients.

JenaValve announced today that it has received FDA premarket approval (PMA) for its Trilogy transcatheter heart valve system.

SHENZHEN, GUANGDONG, CHINA, March 18, 2026 /EINPresswire.com/ -- The Strategic Shift in the Global Gaming Market The ...

UCSF surgeons have pulled off a milestone that sounds like science fiction but is now solid Bay Area reality. In the medical ...

"I was scared to death because I didn't have a heart for months." A man surviving without a real heart got a lucky break -- UCSF completed its first successful artificial heart to donor heart ...

At a potluck, you ate the best chocolate chip cookie—golden-brown, thick and chewy. Unfortunately, you don't know who made the cookie to get the recipe from, so you decide to recreate it. Using ...

Picard Medical (NYSE:PMI), parent company of SynCardia, today announced positive four-year outcomes with its Total Artificial Heart (TAH).

A Monash-led research project is redefining mechanical heart support with a tailored pump designed for the millions of patients living with heart failure.

Milestone procedure gives young father with advanced heart failure a new heart and new future with his family.

A new study revisits a century-old question about how turbulence starts. The findings could potentially influence not only aircraft engineering but even the design of mechanical heart valves, and ...

Rheumatic heart disease is a chronic valvular disorder resulting from acute rheumatic fever, predominantly affecting the mitral valve and characterized by progressive fibrotic thickening. Although the ...